European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Developing new MATerial solutions for cardiac PAce lead and SEnsor encapsulation

Descripción del proyecto

Una solución de bioingeniería para una mejor supervisión cardíaca

En la actualidad, la supervisión intra y posoperatoria incluyen procedimientos que pueden ser invasivos e imprecisos y no proporcionan una supervisión continua. Cardiaccs está desarrollando CardiSense, un dispositivo nuevo, capaz de medir las funciones cardíacas de forma continua y en tiempo real con una precisión y una sensibilidad altas. La financiación europea del proyecto MATPASE permite contratar a un especialista con experiencia en ingeniería mecánica. El objetivo es desarrollar nuevas soluciones de materiales biocompatibles para los componentes de los dispositivos. Esto mejorará la flexibilidad, la encapsulación y la miniaturización de los componentes de los dispositivos para aumentar su seguridad y valor de mercado.

Objetivo

Coronary disease is the leading cause of hospitalization and death worldwide. Serious complications happen in 12-15% of major cardiac surgeries, and are associated with increased morbidity, mortality, and higher costs. Current intra- and post-operative cardiac monitoring approaches used to detect a problem before it becomes a serious complication have significant drawbacks. They can be highly invasive, inaccurate and do not provide continuous monitoring, and patient outcomes can be adversely affected as a result.

Cardiaccs is developing a disruptive medical device called ‘CardiSense’, to address this urgent unmet need for better cardiac function monitoring. CardiSense is the only device of its kind that measures cardiac function continuously, in real-time and with improved sensitivity, making it ideal for use in complex open-heart cardiac surgery patients and potentially allowing intra- and post-operative complications to be avoided, reducing morbidity, mortality and overall care costs.

Although CardiSense provides a ground-breaking solution for cardiac monitoring, the addition of an Innovation Associate (IA) is key to develop the most robust and user-friendly version of our device. We are an SME with limited capacity to mobilize the job market and attract highly skilled professionals to continue the development of CardiSense. Through the SME IA programme we aim to recruit an industrial/mechanical engineer with biocompatible materials science know-how to develop new material solutions for device components. This is key to improving the flexibility, encapsulation and reducing the diameter of the device components that will maximise our market impact.

The MATPASE project will significantly advance and upgrade CardiSense to become an invaluable tool in cardiac monitoring. Not only this, the IA will gain training and hands-on experience that will expand the IA’s employability while simultaneously improving our R&D in-house capabilities for future innovation projects

Convocatoria de propuestas

H2020-INNOSUP-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-INNOSUP-2019-02

Régimen de financiación

CSA - Coordination and support action

Coordinador

CARDIACCS AS
Aportación neta de la UEn
€ 115 698,75
Dirección
Maridalsveien 71B
0458 Oslo
Noruega

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
Norge Oslo og Viken Oslo
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 115 698,75